國立高雄大學圖資館 |

Language: English

Back

Inhibition of late stage enzymes inv...

Helm, Jeremiah Sutter.

Inhibition of late stage enzymes involved in peptidoglycan biosynthesis.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Inhibition of late stage enzymes involved in peptidoglycan biosynthesis.
Author:	Helm, Jeremiah Sutter.
Description:	196 p.
Notes:	Adviser: Suzanne Walker.
Notes:	Source: Dissertation Abstracts International, Volume: 65-06, Section: B, page: 2945.
Contained By:	Dissertation Abstracts International65-06B.
Subject:	Chemistry, Biochemistry.
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3135739
ISBN:	0496829548

Inhibition of late stage enzymes involved in peptidoglycan biosynthesis.
Helm, Jeremiah Sutter.

Inhibition of late stage enzymes involved in peptidoglycan biosynthesis. - 196 p.

Adviser: Suzanne Walker.

Thesis (Ph.D.)--Princeton University, 2004.

Antibiotic resistance is a growing public health concern. Overuse of antibiotics has led to bacterial strains that are no longer sensitive to the most commonly used drugs. As a result there is a real and pressing need for new antibiotics. By studying the structure and mechanism of the enzymes that are involved in peptidoglycan biosynthesis---an excellent antibiotic target---we can design molecules and assays that might help identify new inhibitors. By studying the structure and mechanism of natural product inhibitors that target the enzymes involved in peptidoglycan biosynthesis, we can design analogues with better antibiotic activity and pharmacological properties. These two approaches are complimentary, and can be used to find inhibitors for the same target.

ISBN: 0496829548Subjects--Topical Terms:

226900
Chemistry, Biochemistry.

Inhibition of late stage enzymes involved in peptidoglycan biosynthesis.
LDR:03380nmm _2200289 _450 001 162769
005 20051017073521.5
008 090528s2004 eng d
020 $a 0496829548
035 $a 00149270
040 $a UnM $c UnM
100 0 $a Helm, Jeremiah Sutter. $3 227913
245 1 0 $a Inhibition of late stage enzymes involved in peptidoglycan biosynthesis.
300 $a 196 p.
500 $a Adviser: Suzanne Walker.
500 $a Source: Dissertation Abstracts International, Volume: 65-06, Section: B, page: 2945.
502 $a Thesis (Ph.D.)--Princeton University, 2004.
520 # $a Antibiotic resistance is a growing public health concern. Overuse of antibiotics has led to bacterial strains that are no longer sensitive to the most commonly used drugs. As a result there is a real and pressing need for new antibiotics. By studying the structure and mechanism of the enzymes that are involved in peptidoglycan biosynthesis---an excellent antibiotic target---we can design molecules and assays that might help identify new inhibitors. By studying the structure and mechanism of natural product inhibitors that target the enzymes involved in peptidoglycan biosynthesis, we can design analogues with better antibiotic activity and pharmacological properties. These two approaches are complimentary, and can be used to find inhibitors for the same target.
520 # $a In addition to being a potential antibiotic target, MurG is a prototypical member of a class of enzymes known as the glycosyltransferases. This family of proteins includes enzymes that play roles in a number of different cellular functions including peptidoglycan biosynthesis, antibiotic synthesis, and cellular signaling. Inhibitors of these enzymes have been difficult to design, and we thought that a high throughput screening approach might provide an alternate means to the previously explored rational design strategies. Based on the MurG crystal structure, we designed and synthesized a fluorescently labeled substrate that was subsequently used for high throughput screening of compound libraries. Putative inhibitors were rescreened for activity against MurG in a purified enzyme assay, and then divided into different structural classes. Due to the structural homology between glycosyltransferases, it is possible that the scaffolds identified in the MurG screen could be elaborated into inhibitors for other enzymes.
520 # $a MurG is the final intracellular enzyme involved in peptidoglycan biosynthesis. It was long thought that ramoplanin, a lipoglycodepsipeptide antibiotic, inhibited this enzyme. In fact, ramoplanin is often cited as the only known MurG inhibitor. In this thesis, we demonstrate that MurG is not the target for ramoplanin, and that it instead inhibits the extracellular transglycosylase step of peptidoglycan biosynthesis. Synthetic analogues of ramoplanin helped to deconvolute the mechanism of action of this antibiotic, and provide a starting point for further structure-activity relationship studies.
590 $a School code: 0181.
650 # 0 $a Chemistry, Biochemistry. $3 226900
650 # 0 $a Chemistry, Pharmaceutical. $3 206042
690 $a 0487
690 $a 0491
710 0 # $a Princeton University. $3 212488
773 0 # $g 65-06B. $t Dissertation Abstracts International
790 $a 0181
790 1 0 $a Walker, Suzanne, $e advisor
791 $a Ph.D.
792 $a 2004
856 4 0 $u http://libsw.nuk.edu.tw:81/login?url=http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3135739 $z http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3135739